Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement

Triple-negative breast cancer (TNBC) is the most violent class of tumor and accounts for 20-24% of total breast carcinoma, in which frequently rare mutation occurs in high frequency. The poor prognosis, recurrence, and metastasis in the brain, heart, liver and lungs decline the lifespan of patients...

Full description

Bibliographic Details

Published in:	Materials today bio Vol. 16; p. 100450
Main Authors:	Farheen, Jabeen, Hosmane, Narayan S, Zhao, Ruibo, Zhao, Qingwei, Iqbal, M Zubair, Kong, Xiangdong
Format:	Journal Article
Language:	English
Published:	England Elsevier 01-12-2022
Subjects:	CRISPR/Cas9 Gene therapy Genetic mechanism Nanocarriers Review Triple-negative breast cancer Genetic mechanism CRISPR/Cas9 Gene therapy Nanocarriers Triple-negative breast cancer
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!